The Federal Trade Commission put on hold a lawsuit against pharmacy-benefit manager (PBM) units of UnitedHealth , Cigna and CVS Health over insulin prices after the Trump administration fired two of ...

FTC Chair Andrew Ferguson is no longer recusing himself from the matter, he said two days after a leadership shakeup at the agency left the case in limbo.

The FTC has paused its antitrust case against major PBMs, citing a lack of commissioners. The lawsuit alleges unfair practices that inflated insulin prices.

President Donald Trump last month fired FTC Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya, the only two members participating in the action.

The U.S. Federal Trade Commission’s lawsuit against major pharmacy benefit managers, including UnitedHealth Group’s Optum, ...

Federal Trade Commission Chair Andrew Ferguson has reversed course on his decision to recuse himself from the agency's legal ...

The FTC's general counsel had stayed the administrative complaint because the two FTC commissioners—Chair Andrew Ferguson and Melissa Holyoak—were recused from the case. Ferguson, by withdrawing his ...

Brought forward in September, the FTC lawsuit is accusing CVS Health’s Caremark Rx, Cigna’s Express Scripts and UnitedHealth Group’s OptumRx of “engaging in anticompetitive and unfair ...

The FTC chair had previously been recused from the lawsuit. But after consulting with ethics lawyers, Ferguson changed his ...

CVS Health (NYSE:CVS) said it will close more than 20 pharmacies in Arkansas after the state Gov. Sarah Huckabee Sanders ...

In an unusual move, an audit of commercial health plans by Tennessee officials found that Express Scripts, one of the largest ...

(Reuters) -The Federal Trade Commission put on hold a lawsuit against pharmacy-benefit manager (PBM) units of UnitedHealth, Cigna and CVS Health over insulin prices after the Trump administration ...